Along with lifestyle changes, these therapies help manage diabetes and obesity by: Helping the body release insulin which moves sugar from the blood to the cells to be used for energy Stopping blood sugar spikes by reducing the release of a hormone that raises blood sugar Slowing digestion so people feel full longer and are less likely to overeat Though GLP-1 agonists were first approved by the FDA in 2005, they are still being studied
Shirai, M., Hiramatsu, I., Aoki, Y., Shimoyama, H., Mizuno, T., Nozaki, T., Fukuhara, S., Iwasa, A., Kageyama, S., & Tsujimura, A
People who are recovering from tendon, ligament, or muscle injuries, with persistent gut disorders (IBD, ulcers, leaky gut), inflammation or tissue damage from NSAIDs, wanting speedier surgery or injury recovery, managing brain-gut dysfunction or systemic inflammation
MHT is a member of the scientific advisory board of ERX Pharmaceuticals, Cambridge, Mass